A nomogram prognostic index for risk-stratification in diffuse large B-cell lymphoma in the rituximab era: a multi-institutional cohort study.

Jun CaiXiaopeng TianShuyun MaLiye ZhongWenyu LiLiang WangLinlang GuoZhihua LiYudan WuGuangzheng ZhongHuiqiang HuangZhongjun XiaYi XiaPanpan LiuNing SuYu FangYuchen ZhangQingqing Cai

Published in: British journal of cancer (2021)

We established and validated an accurate prediction model, which performed better than IPI and NCCN-IPI for prognostic stratification of DLBCL patients.

Keyphrases

diffuse large b cell lymphoma
epstein barr virus
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
high resolution
patient reported outcomes
mass spectrometry
hodgkin lymphoma